Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England.
about
Vaccines for measles, mumps and rubella in childrenApplication of Oral Fluid Assays in Support of Mumps, Rubella and Varicella Control ProgramsAssessing mumps outbreak risk in highly vaccinated populations using spatial seroprevalence data.Laboratory diagnosis of mumps in a partially immunized population: The Nova Scotia experience.Infectious diseases and vaccination strategies: how to protect the "unprotectable"?Rapid response to a case of mumps: implications for preventing transmission at a medical research facility.Effectiveness of one dose of mumps vaccine against clinically diagnosed mumps in Guangzhou, China, 2006-2012.A spatial analysis of the spread of mumps: the importance of college students and their spring-break-associated travel.Outbreak-related mumps vaccine effectiveness among a cohort of children and of young adults in Germany 2011.Reemergence of mumps.An assessment of the screening method to evaluate vaccine effectiveness: the case of 7-valent pneumococcal conjugate vaccine in the United StatesMumps complications and effects of mumps vaccination, England and Wales, 2002-2006.Seroprevalence of mumps in The Netherlands: dynamics over a decade with high vaccination coverage and recent outbreaks.Mumps outbreaks in Canada and the United States: time for new thinking on mumps vaccines.Estimation of vaccine efficacy and critical vaccination coverage in partially observed outbreaksAn assessment of mumps vaccine effectiveness by dose during an outbreak in Canada.Mumps antibody response in young adults after a third dose of measles-mumps-rubella vaccineRecent mumps outbreaks in vaccinated populations: no evidence of immune escape.A Mumps Outbreak in Vojvodina, Serbia, in 2012 Underlines the Need for Additional Vaccination Opportunities for Young Adults.Viral etiology of mumps-like illnesses in suspected mumps cases reported in Catalonia, SpainCharacteristics of a large mumps outbreak: Clinical severity, complications and association with vaccination status of mumps outbreak casesDynamics of the serologic response in vaccinated and unvaccinated mumps cases during an epidemicMumps Epidemiology and Mumps Virus Genotypes Circulating in Mainland China during 2013-2015.Factors associated with mumps meningitis and the possible impact of vaccination.Environmental factors potentially associated with mumps transmission in yeshivas during a mumps outbreak among highly vaccinated students: Brooklyn, New York, 2009-2010.Matched case-control study of effectiveness of live, attenuated S79 mumps virus vaccine against clinical mumps.Detection of mumps virus RNA by real-time one-step reverse transcriptase PCR using the LightCycler platformMumps-containing vaccine effectiveness during outbreaks in two schools in Guangdong, China, 2012.Relaxation of purifying selection on live attenuated vaccine strains of the family Paramyxoviridae.Mumps postexposure prophylaxis with a third dose of measles-mumps-rubella vaccine, Orange County, New York, USA.Estimates of mumps seroprevalence may be influenced by antibody specificity and serologic methodEpidemic of mumps among vaccinated persons, The Netherlands, 2009-2012.Influenza vaccine effectiveness: best practice and current limitations of the screening method and their implications for the clinic.Genomic diversity of mumps virus and global distribution of the 12 genotypes.Waning immunity against mumps in vaccinated young adults, France 2013.Real-time reverse transcription-PCR assay for detection of mumps virus RNA in clinical specimens.Are cases of mumps in vaccinated patients attributable to mismatches in both vaccine T-cell and B-cell epitopes?: An immunoinformatic analysis.Assessment of mumps virus-specific antibodies by different serological assays: which test correlates best with mumps immunity?Detection of mumps virus-specific memory B cells by transfer of peripheral blood mononuclear cells into immune-deficient mice.Recommendation of the Advisory Committee on Immunization Practices for Use of a Third Dose of Mumps Virus-Containing Vaccine in Persons at Increased Risk for Mumps During an Outbreak.
P2860
Q24203667-8DC7E2FA-1297-4AD2-8C7D-4F662E5AF9D2Q26774299-231F41D9-CA05-45B3-B2E6-B84FA23D9503Q30765759-440DACEB-5236-407D-BFE3-144E4317F76BQ33593698-9F49A6F0-E6EB-416A-B661-AB5E2D9A9C1AQ33775408-62917088-4E05-487D-B3BF-3ED48063034BQ33842417-51EC0D8D-B25C-4997-AD58-2251A8C0DE65Q34170028-328A56E8-E14A-4E1E-BFAD-2C1B738FEC7BQ34206624-E432C551-779A-4BE2-A59A-E6D9346B7711Q34271491-A9ADCA88-629A-40CB-B0C5-773D3F524E21Q34362910-EF9990C2-1178-49C1-9779-8A689363E450Q34369047-EC2C8649-C3FA-493C-9917-D2A13BF1DBEAQ34628263-444F3471-F1CD-4044-848B-3942D450904BQ34631767-48045081-8A49-4E97-8D6C-2A38D7C00CB2Q34653218-EEA11382-7C24-4270-B0F6-DD86BBECCE51Q34711768-A78BBAC4-5DE2-4C5E-900D-741783EF0960Q35044990-183474E9-2B4F-4DC9-B65A-FE26B2684A45Q35072067-2215CD95-3D35-40E2-87B5-D761FB62A1B2Q35666131-EA2B17F1-172E-4044-B10D-EDC7BEE18483Q35819091-D7C93A3C-1E76-411A-BC91-45684B35FA5EQ35886845-3A7FCB53-F5D5-4AE6-8EEE-98AE126BD214Q35886873-6D20A9E0-9CC1-40D7-AFA7-0A52DB97B3FBQ35887226-39F50243-2084-4AEF-B6B7-752A42BB7CF4Q36248792-3696F40B-6A4A-4A6E-91A5-21E856B9E3C3Q36578928-267EE914-BDEF-4663-A675-79523A9C149BQ36887996-A60FD2D6-5C16-4F24-A327-BE6BE3CA33BBQ36898039-A89B5343-9DAD-4A48-845B-8BA827816ACDQ36994470-5ED0C7E3-8472-4229-B0D0-959BF3A00B61Q37059087-B49B65B2-7832-4BEE-93A1-19835202895DQ37255011-93A589E7-D73F-4CC3-BCBE-2835CD9005C4Q37262391-2FF3DCC5-ECD7-443B-B5C9-AF0905CC7761Q37643341-F402DFE6-CE60-4D81-B037-5868FADA81E5Q37664602-95B11667-E6EA-4558-A605-F2971B5A06F1Q38221641-4CA0519A-4DA6-4121-A3CF-7597C6E4D2CAQ38271449-337D66BC-B92C-410E-A07A-9ED1D97BB93BQ39912221-13D023C2-EE22-469F-94DE-E555EF11AB61Q40443741-908958A3-1A41-4053-A0E4-42528337EA83Q42064365-69B84D7B-844C-4118-9F05-A73B6CDA4CF9Q45367737-F10372AB-C953-4934-B4E9-11DBFB00BD5BQ45374920-C1D2F23F-B01C-435E-BE35-CF5F5B0F826FQ47555251-FC917A1F-3686-4451-B73F-0F9D96372B0C
P2860
Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England.
@ast
Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England.
@en
Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England.
@nl
type
label
Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England.
@ast
Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England.
@en
Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England.
@nl
prefLabel
Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England.
@ast
Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England.
@en
Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England.
@nl
P2093
P2860
P356
P1476
Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England
@en
P2093
David Brown
Emma J Savage
Joanne M White
Judith R Glynn
Nick Andrews
P2860
P356
10.3201/EID1301.060649
P577
2007-01-01T00:00:00Z